Hollowed Agencies Leave U.S. WMD Policy Speculative

Get the Geopolitics newsletter
Daily geopolitics — wars, elections, sanctions, the diplomatic moves that move markets. Free.
- The Trump administration has downsized or eliminated multiple federal agencies addressing unconventional weapons, including the DHS Countering WMD Office, the National Counterproliferation and Biosecurity Center, and the FBI WMD Directorate, while the Air Force's Center for Strategic Deterrence Studies was shut down in 2025.
- Congress and the Defense Department eliminated key advisory bodies: the Counterproliferation Program Advisory Committee's annual report was terminated in 2013, and the Defense Threat Reduction Agency's Threat Reduction Advisory Committee was folded in 2019.
- U.S. Strategic Command hosted annual countering WMD symposia from 2008 to 2017 that connected action officers across policy and technical communities, but these were cancelled after 2023 following a 2018 transfer of coordination duties to U.S. Special Operations Command.
- The Defense Department budget for chemical-biological defense has remained largely flatlined for 20 years, despite stated concerns about Iraq's chemical and biological programs in 2002 and Syria's chemical weapons use.
- Russia continues to use chloropicrin in Ukraine and China is fundamentally rethinking biological warfare, yet speculative scenarios about AI-enabled bioweapons have overtaken these concrete threats in U.S. policy discussions.
- The article identifies four recurring themes degrading the field: budget-to-strategy mismatch, widespread mission creep, new actors entering emerging-tech debates, and jargon abuse — including classifying fentanyl as a chemical weapon and using "biothreat" to redirect funds toward natural disease outbreaks.
Why it matters: The Trump administration's elimination of the DHS Countering WMD Office, FBI WMD Directorate, and Air Force Center for Strategic Deterrence Studies (closed 2025) strips remaining technical expertise from CBRN policy at a time when Russia uses chloropicrin in Ukraine and China rethinks biological warfare. With no agency left to integrate technical analysis into decisions, the cycle of reactive commissions after surprise attacks—last seen after Syria's chemical weapons use—becomes structurally inevitable.



